bosentan anhydrous has been researched along with phorbol 12,13-dibutyrate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babinet, C; Briand, P; Colucci-Guyon, E; Federici, P; Friedlander, G; Henrion, D; Levy, BI; Terzi, F | 1 |
1 other study(ies) available for bosentan anhydrous and phorbol 12,13-dibutyrate
Article | Year |
---|---|
Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Blotting, Northern; Bosentan; Creatinine; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Indomethacin; Kidney; Mice; Mice, Knockout; Mice, Mutant Strains; Muscle, Smooth, Vascular; NADPH Dehydrogenase; Nephrectomy; Nitric Oxide; Nitroarginine; Nitroprusside; Phorbol 12,13-Dibutyrate; RNA, Messenger; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents; Vimentin | 1997 |